UCSF’s 11 Most Popular Health and Science Stories of 2019
Browse the stories that most engaged our readers in 2019.
University of California San Francisco
Give to UCSF
Slideshow: Scenes From Across UCSF in 2019
Take a look back at some special moments captured in the top photos of the past year.
E-Cigarettes Significantly Raise Risk of Chronic Lung Disease, First Long-Term Study Finds
E-cigarette use significantly increases a person’s risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample representative of the entire U.S. adult population.
In Childhood Cancer, Private Insurance Means Better Survival
Children and young adults with pediatric cancer are less likely to be alive five and 10 years following diagnosis if their health insurance is public, compared to those with private insurance.
UC Researchers Advise Healthy California for All Commission
Researchers at the University of California will serve as expert policy guides for the Healthy California for All Commission, which has been charged by the governor and state legislature with developing a path toward universal health coverage in California, including a possible single payer system.
UCSF to Launch Unique Neurology Clinic Specializing in Difficult-to-Diagnose Cases
Patients with ambiguous neurological symptoms, but no diagnosis, frequently go from specialist-to-specialist over a protracted period of time. The new clinic’s goal is to fast-forward the time lapses between appointments by enabling pre-diagnostic screening and expert consultations to take place in a single visit.
Problem Drinkers Have Higher ‘Benzo’ Use, UCSF-Kaiser Permanente Study Shows
Problem drinkers are more likely than teetotalers and moderate drinkers to take benzodiazepines. When taken by heavier drinkers, benzodiazepines may heighten the risk for overdoses and accidents as well as exacerbate psychiatric conditions.
Vijay Ramani Named to Forbes’ ‘30 Under 30’ List
Ramani is featured for co-inventing sci-Plex, a new technique that enables high-throughput chemical screening using single-cell RNA-sequencing as a read-out.
